The 'Stupid Idea' That Made Kevin O'Leary A Massive 20x Return: 'It Was Such A Crazy Pitch, I Bought It Anyway

Kevin O’Leary, known as “Mr. Wonderful” on “Shark Tank,” made a crazy good bet on a wild idea. What if someone pitched you a startup that does genetic testing for cats? Sounds like a head-scratcher. Well, O’Leary thought so too. But he went for it anyway, and it turned out to be one of his best decisions.

Don't Miss:

In 2019, Basepaws, the cat DNA testing company, appeared on “Shark Tank.” Founder Anna Skaya was looking for $250,000 in exchange for 5% of her company. O’Leary and fellow shark Robert Herjavec both bit. They each threw in $125,000 for a 5% stake, valuing the whole company at $2.5 million.

Fast forward a few years, and O’Leary’s gamble paid off big time. On “The Daniel Mac Show,” he called Basepaws his biggest win percentage-wise from “Shark Tank.” He mentioned that he might have paid $50,000 for a 3.5% stake, which valued the company at just $1.4 million. But the real kicker? The company sold for a lot more than anyone expected.

Trending: This startup aims to convince the FDA that Cannabis and Psilocybin can be a better alternative to synthetic pharmaceuticals on the market. Right now you can can invest in while it’s still less than $2/share.

O’Leary had to keep the exact numbers under wraps due to a nondisclosure agreement. But he hinted that the deal was well over the publicly announced $50 million mark. Zoetis, a giant in animal health with an $80 billion market cap, scooped up Basepaws in the second quarter of 2022. Their earnings report showed they spent $93 million on acquisitions that quarter. Basepaws was the only named purchase.

Now, let's do some quick math. Even if Zoetis only paid $50 million for Basepaws, O’Leary could have made around $2.5 million if he had a 5% stake. That's roughly 20 times his money. But if the deal was closer to the $93 million Zoetis spent, he might have walked away with as much as $4.5 million. That would have turned his $50,000 investment into a 90x return.

Trending: A billion-dollar investment strategy with minimums as low as $10 — you can become part of the next big real estate boom today.

So why did Zoetis pay up? Basepaws was on a tear, expanding from just cat DNA tests to dog tests too. When Skaya first pitched to the sharks, the company had only done $200,000 in sales. But in the 18 months following the show, sales shot up to $3.5 million.

O’Leary gives a lot of credit to Skaya. "I invested in Anna for Anna," he said in a video, praising her knack for marketing and growing the business. She turned that little startup into a booming enterprise, and O’Leary's bet paid off in spades.

But Basepaws isn't the only time O’Leary struck gold on “Shark Tank.” His biggest dollar win? A meal-kit company called Plated, which Albertsons bought for about $300 million in 2017. O’Leary knows how to pick ‘em, even when the ideas seem a little out there.

Read Next:

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: StartupsKevin O' Learynews access
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!